NGNE

Neurogene Inc. - Common Stock (NGNE)

About Neurogene Inc. - Common Stock (NGNE)

Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.

Details

Daily high
$15.67
Daily low
$14.84
Price at open
--
52 Week High
$74.49
52 Week Low
$6.88
Market cap
219.8M
Dividend yield
0.00%
Volume
4
Avg. volume
383,909
P/E ratio
-3.35

Neurogene Inc. - Common Stock News

Details

Daily high
$15.67
Daily low
$14.84
Price at open
--
52 Week High
$74.49
52 Week Low
$6.88
Market cap
219.8M
Dividend yield
0.00%
Volume
4
Avg. volume
383,909
P/E ratio
-3.35